Heligenics Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.18M
- Investors
-
2
Heligenics General Information
Description
Developer of a medicinal drug intended to prevent disease and heal patients afflicted with illness through genomics. The company's platform revolutionizes genetic testing and drug discovery by determining the function of genetic variation can comprehensively measure the functional significance of naturally occurring mutations in the human genome, enhancing the accuracy of genetic testing whether for rare diseases or cancer, enabling the medical industry to get an enhanced genetic test interpretation and the pharmaceutical companies to empower conversion of generic drugs into targeted precision medicines.
Contact Information
Website
www.heligenics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
- 833 Las Vegas Boulevard North
- Suite B
- Las Vegas, NV 89101
- United States
+1 (415) 000-0000
Heligenics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 15-Dec-2020 | $1.18M | 00.000 | 00.000 | Completed | Generating Revenue |
| 1. Grant | 01-Jan-2015 | 00.00 | Completed | Generating Revenue |
Heligenics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Heligenics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Martin Schiller Ph.D | Founder, Chief Executive Officer & Chairman |
Heligenics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Asa Lanum | Self | Chairman of Advisory Board | 000 0000 |
| Martin Schiller Ph.D | Heligenics | Founder, Chief Executive Officer & Chairman | 000 0000 |
| Scott Hallman | Heligenics | Board Member | 000 0000 |
| Stan Schiller | Self | Board Member | 000 0000 |
Heligenics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Heligenics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Battle Born Growth | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Nevada Governor's Office of Economic Development | Government | 000 0000 | 000000 0 |